Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers
Pablo Tebas(University of Pennsylvania), Steven D. Douglas(Purdue University West Lafayette), Angela Winters(Children's Hospital of Philadelphia), Florin Tuluc(Children's Hospital of Philadelphia), Wayne Wagner, Renae Catalano(Westat (United States)), Sergei Spitsin, Deborah Kim(University of Pennsylvania), Dwight L. Evans(California University of Pennsylvania), Jeffrey S. Barrett(Aridhia (United Kingdom)), Okan U. Elci(Westat (United States)), James Korelitz(Westat (United States))
Cited by 38
Related Papers
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
|Proceedings of the National Academy of Sciences|1998|566
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.
|Proceedings of the National Academy of Sciences|1995|460